Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), developer of CardioDialysisTM, a medical device that enables continuous broad-spectrum clearance of inflammatory and pathogenic ...
Emerging cardiovascular technology, trends in ambulatory care, provider and payer partnerships, and value-based arrangements create strategic opportunities to address service demand and cost pressures ...
Leveraging Advanced AI and 3D Modeling, Heartflow Provides Cardiologists with Non-Invasive Analysis for Accurate Coronary Artery Disease Detection and Optimized Patient Care ORLANDO, Fla., March 24, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One person dies of cardiovascular disease (CVD) every 34 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For many hospitals, it’s a high-stakes scramble to keep ...
Cardiovascular diseases remain the leading cause of global mortality, necessitating robust screening programs. Multidisciplinary care teams reduce mortality rates in complex heart failure patients ...
Before selecting any clinical treatment or modality, a comprehensive and also unbiased review and understanding of the clinical evidence is critical for the best patient outcomes. Three examples of ...
Boston Scientific BSX, a prominent global player in cardiovascular technology, is well-positioned to capitalize on the robust expansion of the cardiovascular devices market. According to a ...
You may consider yourself an expert in affairs of the heart (or, like many of us, less than expert but determined to keep going), but can you work an EKG machine? How about defibrillator paddles? For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results